Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...

(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in ... late-stage ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the ...

Novo Nordisk reported forecast-beating third-quarter sales of its popular Wegovy weight-loss drug on Wednesday, reassuring ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...